C4 Therapeutics, Inc. (CCCC) Earnings
|
Expand Research on CCCC
| Next EPS Date | 10/29/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +11.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/26  |
Q326 | N/A | -$0.22 | N/A | N/A | $4.78M | N/A | N/A | N/A | ||
| 8/11/26 |
Q226 | -$0.18 | -$0.21 | +$0.03 | $6.64M | $8.2M | N/A |  | | Details | |
| 5/12/26 |
Q126 | -$0.20 | -$0.25 | +$0.05 | $6.15M | $4.8M | N/A | | | Details | |
| 2/26/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/24/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/23/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/20/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/19/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A |
